Acyclovir ophth oint 3percent wobliquev,Ciprofloxacin HCL 0point3percent PLUS Dexamethasone 0point1
Armed Forces Tribunal
BARAMULLA, JAMMU & KASHMIR
Posted:
28 January 2025
Closed:
18 February 2025
GEM
GEM
Invitation to Bid - Nasal Decongestant Spray Xylometazoline HCL 0 1 percent wv bottle of 10 ml,Nasal Drop Xylometazolin in AMBALA, HARYANA
Progress
RAIssue17-Mar-2025, 6:49 pm
Reverse Auction13-Apr-2025, 10:00 am
AwardCompleted
Quantity
942281
Bid Type
Two Packet Bid
Categories
22
ANTIEMETICS CHOLINERGIC DRUGS ACID CHOLINERGIC BLOCKING AGENTS TUBE NASAL SPRAY ANTIPSYCHOTIC AGENTS FOLIC ACID CALCIUM SUPPLY NASAL DECONGESTANTS BENZODIAZEPINES ASCORBIC ACID TRANSITION METALS HYPNOTICS ANTITUBERCULAR DRUGS ANTICONVULSANTS ANTISPASMODICS BUTAPHOSPHAN COUGH AND COLD MEDICINE BROMHEXINE COAGULANT DRUGS VITAMINS
Indian Army announces a tender for Nasal Decongestant Spray Xylometazoline HCL 0 1 percent wv bottle of 10 ml, Nasal Drop Xylometazoline Hcl 0 05 percent paed, Syp Cyproheptadine Hcl 2 mg 5 ml bott of 100 ml, Syp Ondansetron 2 mg 5ml in bott of 30 m, Syp Calcium Phosphate plus Vitamin D3 Bott of 200 ml, Tab Alprazolam 0 point 25mg, Tab Bupropion Hcl SR 150mg, Tab Chlordiazepoxide 10mg, Tab Clonazepam 0 point 5mg, Tab Clozapine 100mg, Tab Duloxetine 20mg, Fluoxetine 20mg Cap, Tab Haloperidol 5mg, Tab Imipramine 25mg, Tab Mementine 10mg, Tab Lithium corbonate 300mg, Tab Risperidone 2mg, Tab Aripiprazole 10mg, Tab Olanzapine 10mg, Tab Olanzepine 5mg, Tab Rivastigmine 1 point 5mg, Tab Sertaline 50mg, Venlafexine 37 point 5mg Cap, Tab Zolpidem 10mg, Tab Quetiapine 50mg, Tab Tianaptine 12 point 5mg, Tab Paroxetine 12 point 5mg, Tab Quetiapine 100mg, Resp Soln Ipratropium Bromide 500mcg 2ml, Resp Soln Levoslabutamol sulphate Resp of 2 point 5ml, Inh Tiotropium Bromide 9 mcg 120 metered does unit, Syp Terbutaline sulphate 1 point 25 mg plus Bromhexine HCl 4 mg plus Guaiphenesin 50 mg per 5 ml bottle of 100 ml, Tab Cough Lozenges each containing Noscapine 10 mg, Tab Mirabegron 25 mg, Tab Alfuzocin 10mg, Ung Anti phlebitis Tube of 15 20 gm, Tab Cilostazole 100mg, Tab Sildenafil citrate 50 mg, Tab Tolterodine Tartrate 2mg, Tab Drotaverine 40mg, Tab Finasteride 5mg, Tab Ascorbic Acid 100mg, Tab Vitamin B complex Containing Vit B1 5mg plus Vit B6 3mg plus Vit B12 5mcg, Tab Calcium Gluconate 500 mg, Syp Iron with vitamins each 5 ml containing Ferrous Fumarate Folic acid Vitamin B12 10 mcg Bott of 200 ml, Vitamin B1 100mg B6 100mg and B12 1000mcg Inj amp of 3ml, Tab Ethambutol 800mg, Tab Theophyllin SR 400mg, Tab Sulphasalazine 1000mg, Ung Amorolfine 0 point 25 percent Tube of 30 Gm in AMBALA, HARYANA. Quantity: 942281. Submission Deadline: 07-04-2025 19: 00: 00. Last date to apply is approaching fast!
Documents 4
GeM-Bidding-7652688.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Past Similar Tenders
(Historical Results)
5 found
Acebrophylline 100Mg and Acetylcystenie 600Mg Tab,Alfuzosin 10 mg Tab,Aripiprazole 10 mg Tab,Aristo
Dg Armed Forces Medical Service
KANNUR, KERALA
Posted:
24 May 2025
Closed:
14 June 2025
GEM
Tab salbutamol 4mg,Chloroquine phosphate 250mg Tab,Cinnarazine 25mg Tab,Tab Clozapine 100mg,Tab pan
Indian Army
CHAMBA, HIMACHAL PRADESH
Posted:
11 January 2025
Closed:
10 February 2025
GEM
Tab Torsemide 100mg,Cream Luliconazole tube of 15 gm,Vitamin D3 200 IU per ml drops,Mometasone nasa
Indian Army
JALANDHAR, PUNJAB
Posted:
15 February 2025
Closed:
8 March 2025
GEM
Methylcobalamin 500 mcg Tab,Methylprednisolone 8 Mg Tab,Metolazone 2 point5 Mg Tab,Metolazone 5Mg T
Indian Army
KANNUR, KERALA
Posted:
19 December 2025
Closed:
29 December 2025
GEM
Tender Results
Loading results...
Bill of Quantities (BOQ)
50 Items
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Nasal Decongestant Spray Xylometazoline HCL 0 1 percent wv bottle of 10 ml | Nasal Decongestant Spray Xylometazoline HCL 0 1 percent wv bottle of 10 ml | 645 | bott | recv@mh123 | 20 |
| 2 | Nasal Drop Xylometazoline Hcl 0 05 percent paed | Nasal Drop Xylometazoline Hcl 0 05 percent paed | 34 | bott | recv@mh123 | 20 |
| 3 | Syp Cyproheptadine Hcl 2 mg 5 ml bott of 100 ml | Syp Cyproheptadine Hcl 2 mg 5 ml bott of 100 ml | 1,680 | bott | recv@mh123 | 20 |
| 4 | Syp Ondansetron 2 mg 5ml in bott of 30 m | Syp Ondansetron 2 mg 5ml in bott of 30 m | 36 | bott | recv@mh123 | 20 |
| 5 | Syp Calcium Phosphate plus Vitamin D3 Bott of 200 ml | Syp Calcium Phosphate plus Vitamin D3 Bott of 200 ml | 3,498 | bott | recv@mh123 | 20 |
| 6 | Tab Alprazolam 0 point 25mg | Tab Alprazolam 0 point 25mg | 51,270 | no | recv@mh123 | 20 |
| 7 | Tab Bupropion Hcl SR 150mg | Tab Bupropion Hcl SR 150mg | 2,280 | no | recv@mh123 | 20 |
| 8 | Tab Chlordiazepoxide 10mg | Tab Chlordiazepoxide 10mg | 17,460 | no | recv@mh123 | 20 |
| 9 | Tab Clonazepam 0 point 5mg | Tab Clonazepam 0 point 5mg | 35,017 | no | recv@mh123 | 20 |
| 10 | Tab Clozapine 100mg | Tab Clozapine 100mg | 1,600 | no | recv@mh123 | 20 |
| 11 | Tab Duloxetine 20mg | Tab Duloxetine 20mg | 45,660 | no | recv@mh123 | 20 |
| 12 | Fluoxetine 20mg Cap | Fluoxetine 20mg Cap | 25,620 | no | recv@mh123 | 20 |
| 13 | Tab Haloperidol 5mg | Tab Haloperidol 5mg | 2,220 | no | recv@mh123 | 20 |
| 14 | Tab Imipramine 25mg | Tab Imipramine 25mg | 1,170 | no | recv@mh123 | 20 |
| 15 | Tab Mementine 10mg | Tab Mementine 10mg | 4,330 | no | recv@mh123 | 20 |
| 16 | Tab Lithium corbonate 300mg | Tab Lithium corbonate 300mg | 4,800 | no | recv@mh123 | 20 |
| 17 | Tab Risperidone 2mg | Tab Risperidone 2mg | 8,010 | no | recv@mh123 | 20 |
| 18 | Tab Aripiprazole 10mg | Tab Aripiprazole 10mg | 3,570 | no | recv@mh123 | 20 |
| 19 | Tab Olanzapine 10mg | Tab Olanzapine 10mg | 9,000 | no | recv@mh123 | 20 |
| 20 | Tab Olanzepine 5mg | Tab Olanzepine 5mg | 15,000 | no | recv@mh123 | 20 |
| 21 | Tab Rivastigmine 1 point 5mg | Tab Rivastigmine 1 point 5mg | 2,155 | no | recv@mh123 | 20 |
| 22 | Tab Sertaline 50mg | Tab Sertaline 50mg | 20,770 | no | recv@mh123 | 20 |
| 23 | Venlafexine 37 point 5mg Cap | Venlafexine 37 point 5mg Cap | 4,140 | no | recv@mh123 | 20 |
| 24 | Tab Zolpidem 10mg | Tab Zolpidem 10mg | 14,850 | no | recv@mh123 | 20 |
| 25 | Tab Quetiapine 50mg | Tab Quetiapine 50mg | 9,275 | no | recv@mh123 | 20 |
| 26 | Tab Tianaptine 12 point 5mg | Tab Tianaptine 12 point 5mg | 4,290 | no | recv@mh123 | 20 |
| 27 | Tab Paroxetine 12 point 5mg | Tab Paroxetine 12 point 5mg | 13,770 | no | recv@mh123 | 20 |
| 28 | Tab Quetiapine 100mg | Tab Quetiapine 100mg | 7,590 | no | recv@mh123 | 20 |
| 29 | Resp Soln Ipratropium Bromide 500mcg 2ml | Resp Soln Ipratropium Bromide 500mcg 2ml | 318 | no | recv@mh123 | 20 |
| 30 | Resp Soln Levoslabutamol sulphate Resp of 2 point 5ml | Resp Soln Levoslabutamol sulphate Resp of 2 point 5ml | 19,440 | no | recv@mh123 | 20 |
| 31 | Inh Tiotropium Bromide 9 mcg 120 metered does unit | Inh Tiotropium Bromide 9 mcg 120 metered does unit | 639 | amp | recv@mh123 | 20 |
| 32 | Syp Terbutaline sulphate 1 point 25 mg plus Bromhexine HCl 4 mg plus Guaiphenesin 50 mg per 5 ml bottle of 100 ml | Syp Terbutaline sulphate 1 point 25 mg plus Bromhexine HCl 4 mg plus Guaiphenesin 50 mg per 5 ml bottle of 100 ml | 5,598 | bott | recv@mh123 | 20 |
| 33 | Tab Cough Lozenges each containing Noscapine 10 mg | Tab Cough Lozenges each containing Noscapine 10 mg | 12,000 | no | recv@mh123 | 20 |
| 34 | Tab Mirabegron 25 mg | Tab Mirabegron 25 mg | 14,700 | no | recv@mh123 | 20 |
| 35 | Tab Alfuzocin 10mg | Tab Alfuzocin 10mg | 2,100 | no | recv@mh123 | 20 |
| 36 | Ung Anti phlebitis Tube of 15 20 gm | Ung Anti phlebitis Tube of 15 20 gm | 358 | tube | recv@mh123 | 20 |
| 37 | Tab Cilostazole 100mg | Tab Cilostazole 100mg | 2,320 | no | recv@mh123 | 20 |
| 38 | Tab Sildenafil citrate 50 mg | Tab Sildenafil citrate 50 mg | 1,809 | no | recv@mh123 | 20 |
| 39 | Tab Tolterodine Tartrate 2mg | Tab Tolterodine Tartrate 2mg | 6,000 | no | recv@mh123 | 20 |
| 40 | Tab Drotaverine 40mg | Tab Drotaverine 40mg | 16,950 | no | recv@mh123 | 20 |
| 41 | Tab Finasteride 5mg | Tab Finasteride 5mg | 3,900 | no | recv@mh123 | 20 |
| 42 | Tab Ascorbic Acid 100mg | Tab Ascorbic Acid 100mg | 16,800 | no | recv@mh123 | 20 |
| 43 | Tab Vitamin B complex Containing Vit B1 5mg plus Vit B6 3mg plus Vit B12 5mcg | Tab Vitamin B complex Containing Vit B1 5mg plus Vit B6 3mg plus Vit B12 5mcg | 399,600 | no | recv@mh123 | 20 |
| 44 | Tab Calcium Gluconate 500 mg | Tab Calcium Gluconate 500 mg | 105,000 | no | recv@mh123 | 20 |
| 45 | Syp Iron with vitamins each 5 ml containing Ferrous Fumarate Folic acid Vitamin B12 10 mcg Bott of 200 ml | Syp Iron with vitamins each 5 ml containing Ferrous Fumarate Folic acid Vitamin B12 10 mcg Bott of 200 ml | 3,495 | bott | recv@mh123 | 20 |
| 46 | Vitamin B1 100mg B6 100mg and B12 1000mcg Inj amp of 3ml | Vitamin B1 100mg B6 100mg and B12 1000mcg Inj amp of 3ml | 2,178 | amp | recv@mh123 | 20 |
| 47 | Tab Ethambutol 800mg | Tab Ethambutol 800mg | 480 | no | recv@mh123 | 20 |
| 48 | Tab Theophyllin SR 400mg | Tab Theophyllin SR 400mg | 13,410 | no | recv@mh123 | 20 |
| 49 | Tab Sulphasalazine 1000mg | Tab Sulphasalazine 1000mg | 5,200 | no | recv@mh123 | 20 |
| 50 | Ung Amorolfine 0 point 25 percent Tube of 30 Gm | Ung Amorolfine 0 point 25 percent Tube of 30 Gm | 246 | tube | recv@mh123 | 20 |
Required Documents
1
Experience Criteria
2
Past Performance
3
Bidder Turnover
4
Certificate (Requested in ATC)
5
OEM Authorization Certificate
6
OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
7
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Reverse Auction Schedule
Start
13-Apr-2025, 10:00 am
End
17-Apr-2025, 1:00 pm
Duration: 99 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 07-04-2025 08:22:54 | Evaluated |
| 2 | ********** Under PMA | - | 07-04-2025 18:58:45 | Evaluated |
| 3 | ********** Under PMA | - | 07-04-2025 12:21:16 | Evaluated |
| 4 | ********** Under PMA | - | 07-04-2025 17:47:06 | Evaluated |
| 5 | ********** Under PMA | - | 07-04-2025 12:26:13 | Evaluated |
| 6 | ********** Under PMA | - | 07-04-2025 18:29:16 | Evaluated |
| 7 | ********** Under PMA | - | 19-03-2025 13:16:55 | Evaluated |
| 8 | ********** Under PMA | - | 03-04-2025 19:48:53 | Evaluated |
| 9 | ********** Under PMA | - | 05-04-2025 17:25:38 | Evaluated |
| 10 | ********** Under PMA | - | 07-04-2025 15:50:07 | Evaluated |
| 11 | ********** Under PMA | - | 03-04-2025 18:59:22 | Evaluated |
| 12 | ********** Under PMA | - | 03-04-2025 16:59:11 | Evaluated |
| 13 | ********** Under PMA | - | 07-04-2025 16:01:07 | Evaluated |
| 14 | ********** Under PMA | - | 23-03-2025 19:58:48 | Evaluated |
| 15 | ********** Under PMA | - | 04-04-2025 16:16:29 | Evaluated |
| 16 | ********** Under PMA | - | 04-04-2025 16:27:34 | Evaluated |
| 17 | ********** Under PMA | - | 05-04-2025 12:56:23 | Evaluated |
| 18 | ********** Under PMA | - | 07-04-2025 12:01:13 | Evaluated |
| 19 | ********** Under PMA | - | 23-03-2025 18:51:57 | Evaluated |
| 20 | ********** Under PMA | - | 04-04-2025 17:36:05 | Evaluated |
| 21 | ********** Under PMA | - | 05-04-2025 17:07:21 | Evaluated |
| 22 | ********** Under PMA | - | 07-04-2025 18:26:10 | Evaluated |
| 23 | ********** Under PMA | - | 18-03-2025 15:00:56 | Evaluated |
| 24 | ********** Under PMA | - | 07-04-2025 18:55:11 | Evaluated |
| 25 | ********** Under PMA | - | 07-04-2025 18:28:01 | Evaluated |
| 26 | ********** Under PMA | - | 24-03-2025 17:41:53 | Evaluated |
| 27 | ********** Under PMA | - | 05-04-2025 16:51:50 | Evaluated |
| 28 | ********** Under PMA | - | 07-04-2025 14:17:35 | Evaluated |
| 29 | ********** Under PMA | - | 04-04-2025 11:48:55 | Evaluated |
| 30 | ********** Under PMA | - | 07-04-2025 16:28:05 | Evaluated |
| 31 | ********** Under PMA | - | 05-04-2025 15:14:01 | Evaluated |
| 32 | ********** Under PMA | - | 18-03-2025 17:07:15 | Evaluated |
| 33 | ********** Under PMA | - | 04-04-2025 17:42:31 | Evaluated |
| 34 | ********** Under PMA | - | 05-04-2025 16:30:30 | Evaluated |
| 35 | ********** Under PMA | - | 07-04-2025 16:21:22 | Evaluated |
| 36 | ********** Under PMA | - | 07-04-2025 17:29:39 | Evaluated |
| 37 | ********** Under PMA | - | 03-04-2025 15:36:20 | Evaluated |
| 38 | ********** Under PMA | - | 26-03-2025 19:28:41 | Evaluated |
| 39 | ********** Under PMA | - | 05-04-2025 17:34:41 | Evaluated |
| 40 | ********** Under PMA | - | 05-04-2025 13:34:25 | Evaluated |
| 41 | ********** Under PMA | - | 23-03-2025 18:44:34 | Evaluated |
| 42 | ********** Under PMA | - | 07-04-2025 17:48:55 | Evaluated |
| 43 | ********** Under PMA | - | 03-04-2025 16:56:03 | Evaluated |
| 44 | ********** Under PMA | - | 03-04-2025 15:44:09 | Evaluated |
| 45 | ********** Under PMA | - | 28-03-2025 12:43:05 | Evaluated |
| 46 | ********** Under PMA | - | 06-04-2025 21:39:05 | Evaluated |
| 47 | ********** Under PMA | - | 20-03-2025 15:20:04 | Evaluated |
| 48 | ********** Under PMA | - | 07-04-2025 09:37:03 | Evaluated |
| 49 | ********** Under PMA | - | 07-04-2025 17:20:51 | Evaluated |
| 50 | ********** Under PMA | - | 19-03-2025 12:34:20 | Evaluated |
| 51 | ********** Under PMA | - | 07-04-2025 10:25:57 | Evaluated |
| 52 | ********** Under PMA | - | 27-03-2025 17:09:24 | Evaluated |
| 53 | ********** Under PMA | - | 06-04-2025 18:37:27 | Evaluated |
| 54 | ********** Under PMA | - | 07-04-2025 18:31:49 | Evaluated |
| 55 | ********** Under PMA | - | 07-04-2025 11:36:58 | Evaluated |
| 56 | ********** Under PMA | - | 19-03-2025 15:18:22 | Evaluated |
| 57 | ********** Under PMA | - | 27-03-2025 18:05:33 | Evaluated |
Frequently Asked Questions
Key insights about HARYANA tender market
What are the eligibility requirements for GEM/2025/B/6063576?
The eligibility requirements include being a registered entity with necessary licenses, compliance with relevant pharmaceutical regulations, and experience in providing pharmaceutical products in substantial quantities. Bidders must demonstrate their ability to adhere to health and safety standards and possess certifications that support their qualifications as suppliers.
What certificates are required for submission?
Bidders must provide certificates that demonstrate compliance with technical specifications and quality standards. This includes but is not limited to:
- Manufacturing licenses
- Import/export licenses (where applicable)
- ISO certifications, if available
These certificates ensure that the products meet the necessary health compliance requirements.
What is the payment term for the tender?
Payment terms for this tender typically involve a structured approach based on delivery milestones. This may include:
- An upfront payment against the Performance Security submitted.
- Subsequent payments linked to the successful delivery and acceptance of the supplied medications.
Bidders should specify their payment methods and flexibility in their financial proposals.
What submission methods are accepted for the tender?
All documents in response to this tender must be submitted electronically via the designated procurement portal. Bidders should ensure that all required documentation is uploaded in the accepted formats, which typically include PDF and Excel files. It’s paramount to adhere to the submission guidelines to avoid disqualification.
Are there benefits for MSEs participating in this tender?
Yes, there are specific provisions for Micro, Small, and Medium Enterprises (MSEs) which include preferential treatment in the evaluation process and assistance in understanding the regulations and submission procedures. MSEs are encouraged to apply as the government aims to promote local production and procurement while ensuring the active participation of smaller entities in large tenders like these.
Explore More Opportunities
Quick Access
Unlock Tender Documents
Sign up now to access all documents
Performance Analytics
7-metric analysis with year-wise breakdown
Competitor Intelligence
Multi-dimensional analysis across 6 parameters
Market Penetration
By department, ministry, geography & category
Historical Analysis
Complete tender history with results
Documents 4
GeM-Bidding-7652688.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS